Author name: Leonardo Arias

Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence

After the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape with innovative approaches—and experts say there’s room for all of them.

Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence Read More »

Scroll to Top